Tissue expression
Cell line expression

BCAS1

gene product
AIBC1, NABC1, PMES-2 
This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene. [provided by RefSeq, Apr 2016]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Antigen sequence

Conjugate

Epitope

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
179 antibodies from 26 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
65 antibodies
Invitrogen Antibodies
7 antibodies
LifeSpan BioSciences, Inc.
25 antibodies
GeneTex
2 antibodies
Novus Biologicals
5 antibodies
Boster Biological Technology
1 antibody
OriGene
7 antibodies
Atlas Antibodies
2 antibodies
Proteintech Group
1 antibody
Acris Antibodies GmbH
6 antibodies
Abgent
6 antibodies
Biorbyt
10 antibodies
ProSci
2 antibodies
NovoPro Bioscience Inc.
1 antibody
Abnova Corporation
4 antibodies
QED Bioscience
1 antibody
Wuhan Fine Biotech Co., Ltd.
1 antibody
Aviva Systems Biology
2 antibodies
MyBioSource
2 antibodies
RayBiotech, Inc.
2 antibodies
United States Biological
17 antibodies
MilliporeSigma / Merck KGaA
3 antibodies
Creative Diagnostics
1 antibody
Creative Biolabs
4 antibodies
Abbexa
1 antibody
Rockland Immunochemicals, Inc.
1 antibody